United States · FDA National Drug Code directory
Fetzima
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0456-2240_b4f9c587-d1eb-462b-bad2-ed0ce6d76c57
- Product NDC
- 0456-2240
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- LEVOMILNACIPRAN HYDROCHLORIDE
- Labeler
- Allergan, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130725
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVOMILNACIPRAN HYDROCHLORIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2240-30) · 0456-2240-30
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2240-90) · 0456-2240-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →